EBITDA for Cencora (COR)
According to Cencora's latest reported financial statements, the company's current EBITDA (TTM) is $3.82B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
COR
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$3.82B
YoY change
+11.1%
5Y CAGR
N/A
Peak year (2025)
$3.74B
Cumulative EBITDA
$33.95B
EBITDA history chart for Cencora (COR) from 1994 to 2025
EBITDA history table for Cencora (COR) from 1994 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $3.74B | +11.1% | ||
| 2024 | $3.36B | -1.3% | ||
| 2023 | $3.41B | +9.5% | ||
| 2022 | $3.11B | +7.0% | ||
| 2021 | $2.91B | -161.5% | ||
| 2020 | -$4.73B | -386.7% | ||
| 2019 | $1.65B | -11.5% | ||
| 2018 | $1.87B | +25.3% | ||
| 2017 | $1.49B | -22.4% | ||
| 2016 | $1.92B | +204.4% | ||
| 2015 | $630.77M | -32.8% | ||
| 2014 | $939.18M | -11.8% | ||
| 2013 | $1.07B | -24.0% | ||
| 2012 | $1.40B | +5.4% | ||
| 2011 | $1.33B | +10.7% | ||
| 2010 | $1.20B | +22.9% | ||
| 2009 | $977.61M | +5.3% | ||
| 2008 | $928.80M | -3.3% | ||
| 2007 | $960.43M | +13.5% | ||
| 2006 | $846.14M | +37.2% | ||
| 2005 | $616.93M | -36.4% | ||
| 2004 | $970.69M | +0.3% | ||
| 2003 | $967.77M | +16.1% | ||
| 2002 | $833.49M | +171.0% | ||
| 2001 | $307.59M | +41.9% | ||
| 2000 | $216.73M | +3.8% | ||
| 1999 | $208.70M | +7.1% | ||
| 1998 | $194.90M | +45.6% | ||
| 1997 | $133.90M | +22.3% | ||
| 1996 | $109.50M | +1.5% | ||
| 1995 | $107.90M | -60.4% | ||
| 1994 | $272.40M | — |
EBITDA values are taken from Cencora's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Cencora (COR) reported EBITDA of $3.74B – grew 11.1% year-over-year.
Cencora EBITDA has recorded the values shown across consecutive periods, with a +19.5% compound annual growth rate over 2015–2025 (10 years).
2025 marks the peak EBITDA at $3.74B, with the historical low of -$4.73B recorded in 2020.
Among 8 Healthcare peers, Cencora (COR) ranks 9th; the peer median for EBITDA is $24.21B.
Cencora EBITDA by Year
Cencora EBITDA 2025: $3.74B
Cencora EBITDA in 2025 was $3.74B, grew 11.1% from 2024. This figure represents the highest annual value in the available history.
Cencora EBITDA 2024: $3.36B
Cencora EBITDA in 2024 was $3.36B, edged down 1.3% below 2023.
Cencora EBITDA 2023: $3.41B
Cencora EBITDA in 2023 was $3.41B, grew 9.5% from 2022.
Cencora EBITDA 2022: $3.11B
Cencora EBITDA in 2022 was $3.11B, grew 7.0% from 2021.
Cencora EBITDA 2021: $2.91B
Cencora EBITDA in 2021 was $2.91B.
See more financial history for Cencora (COR).
Sector peers — EBITDA
Companies in the same sector as Cencora, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Cencora's EBITDA?
- Latest reported EBITDA for Cencora (COR) is $3.82B (period ending December 31, 2025).
How has Cencora EBITDA changed year-over-year?
- Cencora (COR) EBITDA changed +11.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Cencora EBITDA?
- Cencora (COR) EBITDA compound annual growth rate is +19.5% over the most recent 10 years available.
When did Cencora EBITDA hit its highest annual value?
- Cencora EBITDA reached its highest annual value of $3.74B in 2025.
What was Cencora EBITDA in 2024?
- Cencora (COR) EBITDA in 2024 was $3.36B.
What was Cencora EBITDA in 2025?
- Cencora (COR) EBITDA in 2025 was $3.74B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
COR Overview
Company profile, financial tools, and key metrics
COR Revenue Counter
Earns $10,330 every second. See per minute, hour, and day.
COR Earnings Counter
Earns $51.54 per second net profit. See per minute, hour, and day.
COR Economic Scale
Exceeds Portugal's GDP. Compare with world economies.
COR What If Invested
What if you had invested $1,000? See historical returns from any date.
COR How It Makes Money
Discover visual breakdown of $325.78B in revenue — where it comes from and where it goes.
COR Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
COR Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
COR Daily Price Character
Steady · 51.0% historical win rate (green days). Streaks & record days.
COR Buybacks
0.08% TTM buyback yield. Shareholder yield & SBC comparison.
COR Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
COR Dividend Profile
Yield: 0.74%. Safety: 6/8. See full history.
COR Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
COR Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.